Human medicines European public assessment report (EPAR): Steglujan, ertugliflozin / sitagliptin, Diabetes Mellitus, Type 2, Date of authorisation: 23/03/2018, Revision: 4, Status: Authorised

Case Medical Research ◽

10.31525/cmr-12043e3 ◽

2019 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Diabetes Mellitus Type 2 ◽

Diabetes Mellitus Type ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Xiliarx, vildagliptin, Diabetes Mellitus, Type 2, Date of authorisation: 19/11/2008, Revision: 16, Status: Authorised

Case Medical Research ◽

10.31525/cmr-3996de ◽

2018 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Diabetes Mellitus Type 2 ◽

Diabetes Mellitus Type ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Invokana, canagliflozin, Diabetes Mellitus, Type 2, Date of authorisation: 15/11/2013, Revision: 13, Status: Authorised

Case Medical Research ◽

10.31525/cmr-116dee6 ◽

2019 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Diabetes Mellitus Type 2 ◽

Diabetes Mellitus Type ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Qtrilmet, metformin hydrochloride / saxagliptin / dapagliflozin, Diabetes Mellitus, Type 2, Date of authorisation: 11/11/2019, Status: Authorised

Case Medical Research ◽

10.31525/cmr-23f0dba ◽

2019 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Diabetes Mellitus Type 2 ◽

Diabetes Mellitus Type ◽

Metformin Hydrochloride ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Byetta, exenatide, Diabetes Mellitus, Type 2, Date of authorisation: 20/11/2006, Revision: 22, Status: Authorised

Case Medical Research ◽

10.31525/cmr-11ef046 ◽

2019 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Diabetes Mellitus Type 2 ◽

Diabetes Mellitus Type ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Steglatro, ertugliflozin, Diabetes Mellitus, Type 2, Date of authorisation: 21/03/2018, Revision: 4, Status: Authorised

Case Medical Research ◽

10.31525/cmr-119e08a ◽

2019 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Diabetes Mellitus Type 2 ◽

Diabetes Mellitus Type ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Eucreas, vildagliptin / metformin, Diabetes Mellitus, Type 2, Date of authorisation: 14/11/2007, Revision: 18, Status: Authorised

Case Medical Research ◽

10.31525/cmr-208eb19 ◽

2019 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Diabetes Mellitus Type 2 ◽

Diabetes Mellitus Type ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Glubrava, pioglitazone / metformin, Diabetes Mellitus, Type 2, Date of authorisation: 11/12/2007, Revision: 16, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1a07d43 ◽

2019 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Diabetes Mellitus Type 2 ◽

Diabetes Mellitus Type ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Ebymect, dapagliflozin / metformin, Diabetes Mellitus, Type 2, Date of authorisation: 15/11/2015, Revision: 11, Status: Authorised

Case Medical Research ◽

10.31525/cmr-587210 ◽

2019 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Diabetes Mellitus Type 2 ◽

Diabetes Mellitus Type ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Januvia, sitagliptin, Diabetes Mellitus, Type 2, Date of authorisation: 20/03/2007, Revision: 25, Status: Authorised

Case Medical Research ◽

10.31525/cmr-599616 ◽

2019 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Diabetes Mellitus Type 2 ◽

Diabetes Mellitus Type ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Trulicity, dulaglutide, Diabetes Mellitus, Type 2, Date of authorisation: 21/11/2014, Revision: 10, Status: Authorised

Case Medical Research ◽

10.31525/cmr-fdc55a ◽

2019 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Diabetes Mellitus Type 2 ◽

Diabetes Mellitus Type ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text